1.
Naeemikia F, Reynolds J, Dong C, Pritchard JR. Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemia. haematol [Internet]. 2020Sep.10 [cited 2026Feb.6];. Available from: https://haematologica.org/article/view/13140